Leila Chirayath Janah, Samasource: Being Female in a Male World

Video Interview with Leila Chirayath Janah, CEO & Founder Samasource.  Leila first developed the idea behind Samasource while working as a management consultant at Katzenbach Partners (now Booz & Co.), where her clients included global leaders in the outsourcing and telecom sectors and a number of prominent non-profits. Along with Professors Thomas Pogge and Aidan Hollis, she founded Incentives for Global Health and helped produce a plan for incentivizing the development of new drugs for neglected diseases. As an undergraduate, Leila authored background papers for the World Bank’s Development Research Group and Ashoka on equity and social rights. You can find Leila on Twitter @leila_c & blogging @Social Edge

Read more

Beth Seidenberg, KPCB: Training in Venture Capital Success for Women

Video interview with Beth Seidenberg,MD,  partner @ Kleiner Perkins Caufield and Byers.  Beth joined Kleiner Perkins Caufield & Byers in May 2005 to work in the life sciences area.  For the past 20 years, she has focused her career on introducing new innovative treatments for AIDS, arthritis, asthma, cancer, psoriasis, cardiovascular, metabolic, neurological and renal disorders. She introduced 10 innovative products to market and achieved over 40 regulatory approvals (including new indications and formulations) on a worldwide basis. These products have been successfully commercialized and have generated several billion dollars of revenue.

Read more

Beth Seidenberg, KPCB: Training in Venture Capital Success for Women

Video interview with Beth Seidenberg,MD,  partner @ Kleiner Perkins Caufield and Byers.  Beth joined Kleiner Perkins Caufield & Byers in May 2005 to work in the life sciences area.  For the past 20 years, she has focused her career on introducing new innovative treatments for AIDS, arthritis, asthma, cancer, psoriasis, cardiovascular, metabolic, neurological and renal disorders. She introduced 10 innovative products to market and achieved over 40 regulatory approvals (including new indications and formulations) on a worldwide basis. These products have been successfully commercialized and have generated several billion dollars of revenue.

Read more